These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7652796)

  • 1. Clinical evaluation of cyclosporine monitoring in blood by specific and nonspecific radioimmunoassay methods in renal transplant patients with stable renal function and nephrotoxicity.
    Sabaté I; Castelao AM; Santos P; Bover J; Martínez JM; Ruiz R; González de la Presa B; Moliner R; Palencia T; Griñó JM
    Transplant Proc; 1995 Aug; 27(4):2254-5. PubMed ID: 7652796
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.
    Niese D
    Transplant Proc; 1995 Apr; 27(2):1849-56. PubMed ID: 7725531
    [No Abstract]   [Full Text] [Related]  

  • 4. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine monotherapy versus OKT3 and cyclosporine versus prednisone and cyclosporine as induction therapy in older renal transplant patients: a multicenter randomized study. Spanish Monotherapy Study Group.
    Transplant Proc; 1994 Oct; 26(5):2522-4. PubMed ID: 7940775
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of infections in renal transplant recipients treated with cyclosporine.
    Carmellini M; Romagnoli J; Pietrabissa A; Di Stefano R; Oleggini M; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1994 Oct; 26(5):2658-9. PubMed ID: 7940832
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of posttransplant time on dose and concentration of cyclosporine in renal transplant patients.
    Sabaté I; Santos P; Castelao AM; Martínez JM; Ruiz R; González de la Presa B; Mesado D; Palencia T; Sebastián MA; Griñó JM
    Transplant Proc; 1995 Aug; 27(4):2252-3. PubMed ID: 7652795
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K; Munn SR; Sterioff S
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract]   [Full Text] [Related]  

  • 9. C2 monitoring of cyclosporine in stable renal transplant patients results in lower costs and improved renal function.
    Domínguez J; Fuenzalida D; Norambuena R; Pais E; Cortes Monroy G; Llanos R
    Transplant Proc; 2005 Apr; 37(3):1583-5. PubMed ID: 15866680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month clinical outcome of cyclosporine microemulsion formulation (Sigmasporin Microral) in stable renal transplant patients previously maintained on sandimmun neoral.
    Al Wakeel JS; Shaheen FA; Mathew MC; Abou Zeinab HM; Al Alfi A; Tarif NM; Al Mousawi MS; Mahmoud TS; Alorrayed AS; Fagir EA; Dham RS; Shaker DS
    Transplant Proc; 2008 Sep; 40(7):2245-51. PubMed ID: 18790205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential monitoring of immunoregulatory T cell subsets in renal transplantation.
    Mestre M; González C; Griño JM; Valls A; Bonete J; Mané E; Corominas M; Bas J; Romeu A; Buendia E
    Transplant Proc; 1992 Feb; 24(1):73-5. PubMed ID: 1539351
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
    Cherqui D; Duvoux C; Salvat A; Lauzet JY; Metreau JM; Julien M; Fagniez PL; Dhumeaux D
    Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
    Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK
    Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
    Banowsky LH; Wright FH; Kothmann R; Floyd M; Vick S
    Transplant Proc; 1996 Aug; 28(4):2121-4. PubMed ID: 8769175
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimization of cyclosporine monotherapy--long-term graft function.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients.
    Cole E; Maham N; Cardella C; Cattran D; Fenton S; Hamel J; O'Grady C; Smith R
    Transplantation; 2003 Jun; 75(12):2086-90. PubMed ID: 12829917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between Banff classification, acute renal rejection scores, and reversal of rejection.
    Gaber LW; Moore LW; Alloway RR; Flax S; Gaber AO
    Transplant Proc; 1995 Feb; 27(1):1019. PubMed ID: 7878784
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful pancreas-renal transplantation without anti-T-cell antibody induction.
    Shapiro ME; Abrams JM; Brown RS; Steinman TI; Strom TB
    Transplant Proc; 1995 Dec; 27(6):3087-8. PubMed ID: 8539857
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study.
    Morales JM; Andres A; Rodriguez Paternina E; Alcazar JM; Montoyo C; Rodicio JL
    Transplant Proc; 1992 Feb; 24(1):89-91. PubMed ID: 1347185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.